Women Infertility Market Report Trends and Growth, Analysis And Pipeline Review, H2 2015: According To Radiant Insights

“Radiant Insights”
Radiantinsights.com has include “Women Infertility Market Report Up To 2015” Size, Share, Growth Prospects to their Database.

Women Infertility – Pipeline Review, H2 2015


Global Markets Direct’s, ‘Women Infertility – Pipeline Review, H2 2015’, provides an overview of the Women Infertility’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Women Infertility, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Women Infertility and special features on late-stage and discontinued projects.

For More Information visit:

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.


• The report provides a snapshot of the global therapeutic landscape of Women Infertility

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Women Infertility and enlists all their major and minor projects

• The report summarizes all the dormant and discontinued pipeline projects

• A review of the Women Infertility products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

• A detailed assessment of monotherapy and combination therapy pipeline projects

• Coverage of the Women Infertility pipeline on the basis of target, MoA, route of administration and molecule type

• Latest news and deals relating related to pipeline products

Reasons to Buy:

• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

• Develop strategic initiatives by understanding the focus areas of leading companies

• Identify and understand important and diverse types of therapeutics under development for Women Infertility

• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

• Devise corrective measures for pipeline projects by understanding Women Infertility pipeline depth and focus of Indication therapeutics

• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Buy a Sample copy of This Report at:

Table of Contents:

Table of Contents 2

List of Tables 6

List of Figures 8

Introduction 9

Global Markets Direct Report Coverage 9

Women Infertility Overview 10

Therapeutics Development 11

Pipeline Products for Women Infertility – Overview 11

Pipeline Products for Women Infertility – Comparative Analysis 12

Women Infertility – Therapeutics under Development by Companies 13

Women Infertility – Therapeutics under Investigation by Universities/Institutes 17

Women Infertility – Pipeline Products Glance 18

Late Stage Products 18

Clinical Stage Products 19

Early Stage Products 20

Unknown Stage Products 21

Women Infertility – Products under Development by Companies 22

Women Infertility – Products under Investigation by Universities/Institutes 27

Women Infertility – Companies Involved in Therapeutics Development 28

AbbVie Inc. 28

Addex Therapeutics Ltd 29

Allergan Plc 30

Related Reports By Radiant Insights:

Global Elderly First Aid Kit Industry 2015 Market:

Europe Baby Scales Industry 2015 Market:

Global Cranial Perforator Industry 2015 Market:

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.radiantinsights.com/research/women-infertility-pipeline-review-h2-2015